Taylor et al.21also analyzed the role of the transcription factor FOXO3a in TN breast tumors and concluded that its expression could serve as a better prognostic marker, especially in tumors positive for Estrogen Receptors (ERs). This evidence concerns the gene ESR1 and breast neoplasm.